Fine Organic Q1 FY27 Results: Profit ₹135.5 Cr, Revenue ₹668

Announcement and why it matters

Fine Organic Industries Limited has released its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY 2026-27). The results were reviewed by the Audit Committee and approved by the Board of Directors at a meeting held on August 7, 2026. For investors, the update provides a clean read on quarterly profitability, cost structure, and earnings per share for both standalone and consolidated reporting. It also clarifies that the statutory auditors have completed a limited review. The company operates in the chemicals space, supplying oleochemical-based additives used across foods, plastics, cosmetics, coatings, and other specialty applications.

Board approval and reporting scope

The company said the Board approved both standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. These results are positioned as a snapshot of financial performance and operational efficiency for the quarter. The approval date is important because it is the formal corporate action that allows the numbers to be published to stock exchanges. The disclosure also highlights that the financials have undergone a limited review process, which is standard for quarterly reporting.

Standalone Q1 FY27: revenue, expenses and profit

On a standalone basis, Fine Organic Industries reported revenue from operations of ₹668.07 crore for Q1 FY27. Total income for the quarter was ₹691.69 crore. Total expenses were ₹508.53 crore, resulting in profit before tax (PBT) of ₹183.16 crore. Tax expenses were reported at ₹47.20 crore, leading to a net profit of ₹135.50 crore for the quarter. The company also reported total comprehensive income of ₹145.70 crore. Earnings per equity share (basic and diluted) were reported at ₹44.19.

Consolidated Q1 FY27: headline numbers

In its consolidated results, Fine Organic Industries reported a net profit of ₹138.14 crore for the quarter ended June 30, 2026. Consolidated revenue from operations stood at ₹694.17 crore, while total income was ₹718.42 crore. Total consolidated expenses were ₹532.94 crore. Consolidated PBT was reported at ₹183.55 crore. Total comprehensive income for the period was ₹148.34 crore. Earnings per equity share (basic and diluted) for the consolidated results were ₹45.06.

Auditor review and conclusion

The company stated that the financial results have undergone a limited review by the statutory auditors, CNK & Associates LLP. The auditors issued an unmodified conclusion on both the standalone and consolidated financial results. The disclosure adds that the statements are free from material misstatement and comply with applicable regulations. For the market, an unmodified conclusion generally supports confidence in the quarterly reporting process and compliance.

Key financial snapshot table

How this compares with the prior quarter snapshot provided

The disclosure also carried a “Quick Details” panel for Q1 FY 2026-27, including the results date as August 07, 2026. In that snapshot, the previous quarter revenue was listed as ₹625.3 crore and previous quarter profit after tax (PAT) as ₹117.5 crore, with a previous quarter EBITDA margin of 20.8%. The same panel listed market cap at ₹14,767.38 crore and CMP at ₹4,816.5. Separately, another market data panel in the provided text showed a share price of ₹5,236.1 and market capitalisation of ₹16,053.87 crore, indicating that market metrics can vary by timestamp and data source.

Stock and trading data mentioned in the release pack

The market data block referenced the company’s NSE symbol FINEORG and BSE code 541557, and tagged the sector as Chemicals. A price point shown was ₹5,236.10, down ₹34.50 (-0.65%), with the timestamp noted as “NSE: 25 Jun 4:00 PM” in the text. The same section listed the day’s high at ₹5,280 and day’s low at ₹5,185. It also provided a 52-week high of ₹5,494 and a 52-week low of ₹3,856. Additional metrics shown included EPS (TTM) of ₹112.97, sales growth of 13.02%, ROE of 19.1%, ROCE of 25.81%, and profit growth of 6.02%.

Historical quarterly data points included

The material also included a quarterly results table (all figures in ₹ crore) running from Mar 2025 to Mar 2026. Net sales were listed as ₹576.25 crore (Mar 2025), ₹559.15 crore (Jun 2025), ₹571.93 crore (Sep 2025), ₹528.59 crore (Dec 2025), and ₹616.31 crore (Mar 2026). Profit after tax in the same table was shown as ₹88.54 crore (Mar 2025), ₹92.85 crore (Jun 2025), ₹95.35 crore (Sep 2025), ₹68.12 crore (Dec 2025), and ₹90.07 crore (Mar 2026). The table also reported adjusted EPS of ₹28.88 (Mar 2025) and ₹29.38 (Mar 2026), among other line items.

Market impact and what investors can take away

From the Q1 FY27 numbers disclosed, the key takeaways are the scale of quarterly revenue, the expense base reported, and the resulting profitability on both standalone and consolidated bases. The standalone EPS of ₹44.19 and consolidated EPS of ₹45.06 provide a per-share lens on quarterly performance as reported. The limited review with an unmodified conclusion from CNK & Associates LLP is a notable compliance datapoint included in the same disclosure set. Meanwhile, the market panels bundled with the update show a wide range of data points, from CMP and market cap to 52-week range, which investors often use to place quarterly results in a trading and valuation context.

Conclusion

Fine Organic Industries’ board-approved unaudited Q1 FY27 results show standalone revenue from operations of ₹668.07 crore and net profit of ₹135.50 crore, while consolidated net profit stood at ₹138.14 crore. The company also reported an unmodified conclusion following a limited review by its statutory auditors. With the results approved on August 7, 2026, the next market focus will typically be on any additional commentary the company provides alongside these financial statements, if released through subsequent filings.